Here, we demonstrate that alloantigen-primed BALB/c and Fas-deficient B6.lpr DN T cells can act as Tregs to inhibit GVHD mediated by syngeneic CD4+ T cells in a semiallogeneic BMT model. The gene discussed is CD4; the disease is graft versus host disease.